Enanta Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ENTA
CUSIP
29251M106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 112 18.6 M $103 M
2024 Q4 112 21.4 M $127 M
2024 Q3 115 21.4 M $222 M
2024 Q2 106 23.7 M $308 M
2024 Q1 114 26.6 M $465 M
2023 Q4 112 21.5 M $203 M
2023 Q3 137 20.2 M $225 M
2023 Q2 137 20.2 M $438 M
2023 Q1 151 19.9 M $806 M
2022 Q4 154 20.8 M $966 M
2022 Q3 167 19.7 M $1.02 B
2022 Q2 159 20.2 M $956 M
2022 Q1 178 19.7 M $1.40 B
2021 Q4 192 18.8 M $1.41 B
2021 Q3 151 19.4 M $1.10 B
2021 Q2 158 18.9 M $831 M
2021 Q1 157 19.4 M $957 M
2020 Q4 161 20.0 M $843 M
2020 Q3 178 18.9 M $863 M
2020 Q2 189 18.3 M $918 M
2020 Q1 167 18.1 M $930 M
2019 Q4 182 18.6 M $1.15 B
2019 Q3 188 17.9 M $1.08 B
2019 Q2 208 17.8 M $1.50 B
2019 Q1 210 18.2 M $1.74 B
2018 Q4 192 17.0 M $1.21 B
2018 Q3 212 16.9 M $1.45 B
2018 Q2 204 15.1 M $1.75 B
2018 Q1 189 14.8 M $1.20 B
2017 Q4 150 14.0 M $824 M
2017 Q3 131 12.8 M $598 M
2017 Q2 127 12.6 M $454 M
2017 Q1 133 12.9 M $397 M
2016 Q4 152 13.4 M $448 M
2016 Q3 139 13.1 M $349 M
2016 Q2 133 13.4 M $296 M
2016 Q1 156 14.2 M $418 M
2015 Q4 142 14.6 M $483 M
2015 Q3 147 16.0 M $593 M
2015 Q2 134 13.8 M $622 M
2015 Q1 119 12.4 M $380 M
2014 Q4 128 10.8 M $552 M
2014 Q3 116 11.3 M $445 M
2014 Q2 101 9.76 M $420 M
2014 Q1 80 8.44 M $337 M